- Telehealth Visits
- Insurances Accepted
Kerstin Morehead, MD
Rheumatology- Telehealth Visits
- Insurances Accepted
Kerstin Morehead, MD
Rheumatology- Telehealth Visits
- Insurances Accepted
On this page
Education
Board Certification
- Rheumatology, American Board of Internal Medicine/Rheumatology
Fellowship
- Rheumatology, UCSF Medical Center - OMAG
Residency
- Internal Medicine, UCSF Medical Center - OMAG
Internship
- Internal Medicine, UCSF Medical Center - OMAG
School
- MD, University of Chicago Pritzker School of Medicine
Academic Title
- Health Sciences Clinical Professor
Care Keywords
Services
Conditions
- Rheumatoid Arthritis
Locations
Provider Research Listing
Browse clinical trials and publications by this provider
Showing 1-6 of 84 reviews
- July 20, 20263.9 out of 5 Stars
Appeared treating physician learned more about my concerns from what I shared with resident internist than from me. Understand this is teaching clinic but felt out of loop' for real time discussion with primary provider
- July 16, 20265 out of 5 Stars
She is a great doctor. Very good at communicating and listening. Personable and compassionate.
- June 3, 20265 out of 5 Stars
I am very pleased with my care provider!
- June 3, 20265 out of 5 Stars
Dr Morehead is by far the best physician I have had. She is so intelligent, focusing on all probabilities that may affect wellness. She is personable, a great communicator and a great sense of humor. I indeed trust her with my life.
- May 29, 20265 out of 5 Stars
Raised questions on lab result outliers, discussed results & significants. Reviewed ongoing shoulder & discussed MRI - monitor & follow up
- May 29, 20265 out of 5 Stars
Great Customer Service
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.